Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Fatty Liver Disease”

1,673 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,673 results

Large-scale testing (Phase 3)Study completedNCT02908152
What this trial is testing

Curcumin Supplement in Nonalcoholic Fatty Liver Patients

Who this might be right for
Type 2 DiabetesNonalcoholic Fatty Liver
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT02948647
What this trial is testing

Healthy Eating Through Reduction Of Excess Sugar

Who this might be right for
NAFLD
University of Southern California 113
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Early research (Phase 1)Study completedNCT06188026
What this trial is testing

A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.

Who this might be right for
Healthy Volunteers (Non-alcoholic Steatohepatitis)
Novo Nordisk A/S 34
Large-scale testing (Phase 3)Study completedNCT01245608
What this trial is testing

Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

Who this might be right for
Cardiovascular Diseases
Tehran University of Medical Sciences 2,400
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Large-scale testing (Phase 3)Study completedNCT01529268
What this trial is testing

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 169
Early research (Phase 1)Ended earlyNCT04766476
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Bristol-Myers Squibb 9
Post-approval studies (Phase 4)Study completedNCT03792321
What this trial is testing

Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)

Who this might be right for
Hypogonadism, MaleDiabetes Mellitus, Type 2Obesity
University Medical Centre Ljubljana 55
Not applicableStudy completedNCT01030484
What this trial is testing

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

Who this might be right for
Liver Disease
Johns Hopkins Bloomberg School of Public Health 2,501
Testing effectiveness (Phase 2)Study completedNCT03576755
What this trial is testing

Spironolactone Therapy In Young Women With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT04048135
What this trial is testing

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

Who this might be right for
NASH
89bio, Inc. 101
Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing

Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218
Large-scale testing (Phase 3)WithdrawnNCT02541045
What this trial is testing

Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Hospital General de Mexico
Not applicableStudy completedNCT05866744
What this trial is testing

Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Agricultural University of Athens 59
Post-approval studies (Phase 4)Study completedNCT05042245
What this trial is testing

The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 237
Not applicableStudy completedNCT00815009
What this trial is testing

Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
San Antonio Military Medical Center 56
Not applicableLooking for participantsNCT04785937
What this trial is testing

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatohepatitis, NonalcoholicLiver Fibroses
Azienda USL Reggio Emilia - IRCCS 50
Not applicableStudy completedNCT01958411
What this trial is testing

Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)

Who this might be right for
AtherosclerosisNon-alcoholic Fatty Liver Disease
Korea University 340
Load More Results